Proteomics International gave a presentation as part of the QEII BioInnovation Showcase and Partneri...
Proteomics International was at Ausbiotech 2017, from 25th to 27th October 2017, at the Adelaide Con...
Proteomics International attended the 16th Human Proteome Organisation World Congress (HUPO) in Dubl...
Proteomics International attended and presented at the Australian Diabetes Society (ADS)/Australian ...
Dr Javed Khan (Business Development/Computational Proteomics Scientist), Mr. Shane Herbert (Customer...
Proteomics International attended the International Proteomics Conference 2017 “Proteomics in Biotec...
Canary Capital will be hosting a PIQ Investor Event at its office in Sydney with Dr Richard Lipscomb...
Proteomics International presented its PromarkerD validation clinical study results at the American ...
Dr Richard Lipscombe (Managing Director), Dr Javed Khan (Business Development/Computational Proteomi...
Proteomics International (PI) is pleased to announce that Dr Richard Lipscombe (Managing Director), ...
Managing director Dr Richard Lipscombe showcasing the company and PromarkerD, the world leading pred...
Managing director Dr Richard Lipscombe showcased the company and PromarkerD, the world leading predi...
Global leader in predictive diagnostics
Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, will adv...